News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
872,489 Results
Type
Article (88139)
Company Profile (825)
Press Release (783506)
Multimedia
Podcasts (204)
Webinars (30)
Section
Business (233336)
Career Advice (4151)
Deals (39892)
Drug Delivery (154)
Drug Development (91467)
Employer Resources (205)
FDA (18424)
Job Trends (17437)
News (398085)
Policy (39989)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3021)
Academic (2)
Accelerated approval (37)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (187)
Alzheimer's disease (1822)
Antibody-drug conjugate (ADC) (367)
Approvals (18618)
Artificial intelligence (668)
Autoimmune disease (185)
Automation (45)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (211)
Biotechnology (490)
Bladder cancer (169)
Brain cancer (67)
Breast cancer (690)
Cancer (5257)
Cardiovascular disease (466)
Career advice (3575)
Career pathing (42)
CAR-T (316)
CDC (65)
Celiac Disease (2)
Cell therapy (866)
Cervical cancer (39)
Clinical research (77302)
Collaboration (1917)
Company closure (5)
Compensation (1220)
Complete response letters (78)
COVID-19 (3001)
CRISPR (105)
C-suite (944)
Cystic fibrosis (155)
Data (6555)
Decentralized trials (2)
Denatured (75)
Depression (160)
Diabetes (548)
Diagnostics (7296)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (325)
Drug pricing (229)
Drug shortages (36)
Duchenne muscular dystrophy (253)
Earnings (100527)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135640)
Executive appointments (1064)
FDA (21754)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1619)
Gene editing (226)
Generative AI (71)
Gene therapy (701)
GLP-1 (1156)
Government (5472)
Grass and pollen (8)
Guidances (389)
Healthcare (20973)
HIV (70)
Huntington's disease (52)
IgA nephropathy (89)
Immunology and inflammation (307)
Immuno-oncology (73)
Indications (126)
Infectious disease (3314)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (130)
Intellectual property (266)
Interviews (817)
IPO (17969)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (72)
Kidney cancer (19)
Labor market (97)
Layoffs (662)
Leadership (42)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (707)
Lymphoma (393)
Machine learning (46)
Management (66)
Manufacturing (909)
MASH (180)
Medical device (15081)
Medtech (15145)
Mergers & acquisitions (23021)
Metabolic disorders (1457)
mRNA (200)
Multiple sclerosis (174)
NASH (23)
Neurodegenerative disease (376)
Neuropsychiatric disorders (108)
Neuroscience (3216)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5120)
Now hiring (69)
Obesity (711)
Opinion (345)
Ovarian cancer (172)
Pain (223)
Pancreatic cancer (247)
Parkinson's disease (311)
Partnered (39)
Patents (541)
Patient recruitment (532)
Peanut (64)
People (67108)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23886)
Phase 2 (33545)
Phase 3 (25262)
Pipeline (5764)
Policy (353)
Postmarket research (3554)
Preclinical (10712)
Press Release (72)
Prostate cancer (266)
Psychedelics (60)
Radiopharmaceuticals (313)
Rare diseases (980)
Real estate (7444)
Recruiting (81)
Regulatory (29277)
Reports (69)
Research institute (2740)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (271)
Series B (205)
Service/supplier (30)
Sickle cell disease (109)
Special edition (28)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (4338)
State (2)
Stomach cancer (21)
Supply chain (115)
Tariffs (101)
The Weekly (127)
Vaccines (1185)
Venture capital (101)
Weight loss (488)
Women's health (102)
Worklife (22)
Date
Today (205)
Last 7 days (791)
Last 30 days (2848)
Last 365 days (32858)
2026 (4802)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (94)
Alaska (7)
Arizona (351)
Arkansas (15)
Asia (51659)
Australia (9077)
California (12013)
Canada (3434)
China (1214)
Colorado (507)
Connecticut (524)
Delaware (360)
Europe (118819)
Florida (1781)
Georgia (386)
Hawaii (4)
Idaho (68)
Illinois (1002)
India (78)
Indiana (567)
Iowa (24)
Japan (456)
Kansas (135)
Kentucky (46)
Louisiana (31)
Maine (84)
Maryland (1498)
Massachusetts (8810)
Michigan (374)
Minnesota (679)
Mississippi (6)
Missouri (144)
Montana (36)
Nebraska (29)
Nevada (130)
New Hampshire (88)
New Jersey (3220)
New Mexico (33)
New York (3168)
North Carolina (1661)
North Dakota (10)
Northern California (5796)
Ohio (372)
Oklahoma (23)
Oregon (55)
Pennsylvania (2397)
Puerto Rico (25)
Rhode Island (51)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4648)
Tennessee (184)
Texas (1890)
United States (43251)
Utah (364)
Vermont (1)
Virginia (303)
Washington D.C. (88)
Washington State (1002)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 872,489 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IPO
How LB Rode the Brutal Capital Markets to One of 2025’s Most Successful IPOs
LB Pharma needed $350 million to advance a promising schizophrenia candidate at a time when the biotech markets were locked up tight. Fortunately, it wasn’t CEO Heather Turner’s first rodeo.
February 25, 2026
·
2 min read
·
Annalee Armstrong
FDA
Opinion: Balancing Safety Access in Rare Disease—Lessons From Sarepta
Regulators overseeing rare disease treatments need better tools to weigh competing risks in real time. Sarepta Therapeutics’ Elevidys is a prime example of why.
February 25, 2026
·
6 min read
·
Joshua R. Mansbach
Rare diseases
Cashing In on ‘Creative Fundamentals’ To Fund Rare Disease R&D
Rare disease drug developers struggle to survive in a biopharma investment market that prioritizes large patient populations. Initiatives like the Orphan Therapeutics Accelerator are attempting to solve what CEO Craig Martin says is not a science problem, but a math problem.
February 25, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Consegna Pharma Highlights Innovative Modeling and Simulation Strategy as FDA Concurs with Regulatory Pathway for CP217 to Prevent Fentanyl Epidemic Deaths
February 24, 2026
·
4 min read
Press Releases
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
February 24, 2026
·
8 min read
Press Releases
Bakar Labs Helps Companies Raise More Than $1 Billion in Its First Four Years of Operation
February 24, 2026
·
4 min read
Press Releases
Linnaeus Therapeutics Awarded Up to $22 Million from ARPA-H to Advance LNS8801 for Healthspan Preservation
February 24, 2026
·
4 min read
Press Releases
Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit
February 24, 2026
·
1 min read
Press Releases
Sarepta Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
February 24, 2026
·
1 min read
Press Releases
Schrödinger to Participate in Upcoming March 2026 Investor Conferences
February 24, 2026
·
1 min read
1 of 87,249
Next
